As October draws to a close, it's time to take a look at the regulatory news that made headlines in the month and look ahead to what's in store for November. Pfizer's Hympavzi ...

Although our cases had different variant types, they shared important similarities on the onset period and prognosis of the symptoms. All cases presented hypotonia, difficulties in swallowing, ...

Of the three types of MS, PPMS is considered the rarest, affecting 10% of people living with MS. As with other forms of MS, ...